A Phase 2 Study of VLX-1005 Versus Placebo in Suspected Heparin Induced Thrombocytopenia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John Alexander, MD
Duke Clinical Research Institute
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Stanford University
Stanford, California, United States
- University of Colorado
Aurora, Colorado, United States
- Yale University
New Haven, Connecticut, United States
- Georgetown University
Washington D.C., District of Columbia, United States
- Medstar Washington Hospital Center
Washington D.C., District of Columbia, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Duke University
Durham, North Carolina, United States
- Oregon Health and Science University
Portland, Oregon, United States
- Thomas Jefferson University
Philadelphia, Pennsylvania, United States
- Universiy of Pennsylvania
Philadelphia, Pennsylvania, United States
- Carilion Medical Center
Roanoke, Virginia, United States
- University of Washington
Seattle, Washington, United States
- Versiti at Froedtert Hospital
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Sept 2023
- Primary completion
- 17 Nov 2025
- Completion
- 17 Nov 2025
- Last update posted
- 25 Nov 2025
- Registered enrollment
- 24
- Registry id
- NCT05785819
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.